Concepedia

Tilmann Lantzsch

TL

Statistics

Publications

22

Citations

1.3K

H-Index

18

Active since

2001

Affiliations

Martin Luther University Halle-Wittenberg(Current)

Krankenhaus St. Elisabeth und St. Barbara

Medical University of Vienna

German Breast group

Johannes Gutenberg University Mainz

Tilmann Lantzsch is an author at Martin Luther University Halle-Wittenberg specializing in medicine, oncology, and breast oncology.

Publications per year

2001–2024

22

Publications

22

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)

Gϋnter von Minckwitz, Gϋnter von Minckwitz, Sibylle Loibl et al. · Annals of Oncology · 2014 · 140 citations

, , +15

Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer

Antje Lebrecht, Christoph Grimm, Tilmann Lantzsch et al. · Tumor Biology · 2004 · 133 citations

, , +16

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 122 citations

, , +13

Lymphatic Mapping of Sentinel Nodes in Early Vulvar Cancer

G. Sliutz, Alexander Reinthaller, Tilmann Lantzsch et al. · Gynecologic Oncology · 2002 · 119 citations

, , +16

Interleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women

Lukas Hefler, Christoph Grimm, Tilmann Lantzsch et al. · Clinical Cancer Research · 2005 · 119 citations

, , +17

1–5 of 22